J Cell Physiol 181: 470-478, 1999
[1] The molecular signaling that links receptor engagement to sustained IGF-1 elevation is explored in our reference on how signaling networks drive tesamorelin-induced IGF-1 elevation
With the dual effect of "diabetes" and "weight loss", the development of GLP-1 long-acting receptor agonists has become a research hotspot at home and abroad
, 1 , , / -B, - (Drucker, 2017)
When food enters the digestive system, GLP-1 is released into the bloodstream, where it exerts multiple beneficial effects on metabolic health, though it has a very short half-life due to rapid degradation by the enzyme dipeptidyl peptidase-4 (DPP-4)
The consequences can be Increased side effects such as nausea, bloating or circulatory problems because the stomach is emptied even more slowly